Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

CUSIP: 05156V102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Shares, no par value
Shares outstanding
132,929,348
Total 13F shares
49,994,676
Share change
-960,799
Total reported value
$547,934,449
Put/Call ratio
97%
Price per share
$10.96
Number of holders
182
Value change
+$7,051,204
Number of buys
87
Number of sells
70

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2023

As of 31 Mar 2023, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 182 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,994,676 shares. The largest 10 holders included BlackRock Inc., ARMISTICE CAPITAL, LLC, NEA Management Company, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and VANGUARD GROUP INC. This page lists 183 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.